{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001699","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.821207+00:00","generated_at":"2026-05-28T04:26:06.635050+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CMS final LCD denies coverage for Interpace's PancraGEN test; company to discontinue after Feb 7, 2025","bullets":["CMS issued final LCD L39365 establishing non-coverage for PancraGEN, a DNA-based test assessing pancreatic cyst cancer risk.","Interpace will stop accepting PancraGEN specimens after February 7, 2025; test primarily ordered for Medicare patients.","PancraGEN has helped over 80,000 patients since 2013; CEO calls decision inconsistent with advancing patient care.","Company plans restructuring but expects to remain profitable with ThyGeNEXT + ThyraMIR v2 thyroid tests.","Interpace will consider all remedies against CMS/Novitas regarding the non-coverage decision."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001699","json":"https://secwatch.observer/filing/0001493152-25-001699.json","markdown":"https://secwatch.observer/filing/0001493152-25-001699.md","text":"https://secwatch.observer/filing/0001493152-25-001699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315225001699/0001493152-25-001699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315225001699/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:26:06.635050+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}